Sign In
Pharma
Rs 10,000 cr biopharma Shakti to make India global hub
Pharma industry shifts from volume to value-led growth
Healthcare
Biocon Biologics gets global rights for biosimilar Adalimumab
Biocon opens first manufacturing plant in US
Indian Pharma To Gain Amid Higher US Tariffs
11% Fall In Regulatory Violations In Indian Pharma In 2024: Report
India’s Pharma Exports Potential To Reach $350 Bn
Telangana State
India, Belgium Explore Partnership In Life Sciences
Industry
Lee Pharma foraying into biosimilars, peptide mkt
Cipla, Kemwell form JV
